Brett Lu is a Psychiatry physician affiliated with University of Hawaiʻi at Mānoa. OpenAlex indexes 37 publications with 900 citations (h-index 12).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
1296 Kapiolani Blvd Apt 3004
Honolulu, HI 968142886
Telephone
808-285-9271Provider last certified this registry record 3 Jan 2024.
Industry payments
16 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Neurocrine BioSciences, Inc.Program year20253 payments
- Alkermes, Inc.Program year20253 payments
- ABBVIE INC.Program year20252 payments
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Nervous system
94%SSRI48.8%Escitalopram Oxalate37%Trazodone Hcl35%Citalopram Hbr28%Part D≥35 patientsAtypical Antipsychotic22.5%Aripiprazole36%Quetiapine Fumarate26%Risperidone20%Olanzapine13%Vraylar5%Part D<11 patients+ 9 more classes in this area
Cardiovascular
2.8%alpha-Adrenergic Blocker1.5%Prazosin Hcl100%Part D<11 patientsCentral alpha-2 Adrenergic Agonist1.3%Clonidine Hcl100%Part D<11 patientsMetabolism & gastrointestinal
1.9%Biguanide (metformin)1.9%Metformin Hcl100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Methamphetamine Use in Psychiatric Emergency Services and Among Asian American and Pacific Islander Populations
Journal of Addiction Medicine
2024 - Impact of psychiatric social workers on length of stay in psychiatric emergency service
Academic Emergency Medicine
2023 - Older Bipolar Patient with Treatment-Refractory Neuropsychiatric Symptoms Due to Lewy Body Dementia: Role of Neuroimaging
Journal of Psychiatry and Psychiatric Disorders
2022 - Effectiveness and Safety of Intravenous Ketamine for Severely Depressed Patients Unable to Receive Electroconvulsive Therapy Due to Medical Risks
The Primary Care Companion For CNS Disorders
2020 - Prevalence of Burnout in Medical and Surgical Residents: A Meta-Analysis
International Journal of Environmental Research and Public Health
2019
Similar KOLs
Other experts from the same institution or the same specialty.
Cecilia Shikuma, MD
University of Hawaiʻi at Mānoa
Todd Seto, MD
University of Hawaiʻi at Mānoa
Brian Issell, MD, FACP
University of Hawaiʻi at Mānoa
Naoky Tsai, MD
University of Hawaiʻi at Mānoa
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”